Willsher, K. (2021, October 11). French study of over 22m people finds vaccines cut severe Covid risk by 90%. The Guardian. https://www.theguardian.com/world/2021/oct/11/french-study-vaccines-cut-covid-deaths

Pozzetto, B., Legros, V., Djebali, S., Barateau, V., Guibert, N., Villard, M., Peyrot, L., Allatif, O., Fassier, J.-B., Massardier-Pilonchéry, A., Brengel-Pesce, K., Yaugel-Novoa, M., Denolly, S., Boson, B., Bourlet, T., Bal, A., Valette, M., Andrieu, T., Lina, B., … Trouillet-Assant, S. (2021). Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature, 1–9. https://doi.org/10.1038/s41586-021-04120-y

Bloom, J., & Cobey, S. (2021, December 12). Opinion | A Scientist’s Guide to Understanding Omicron. The New York Times. https://www.nytimes.com/2021/12/12/opinion/covid-omicron-data.html

Banerjee, P. (2022, February 13). Biological E seeks EUA for its Corbevax vaccine for 12-18 yrs age group. Mint. https://www.livemint.com/news/india/biological-e-seeks-eua-for-its-corbevax-vaccine-for-12-18-yrs-age-group-11644746753338.html

Monto, A. S. (2021). The Future of SARS-CoV-2 Vaccination—Lessons from Influenza. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMp2113403

Lauring, A. S., Tenforde, M. W., Chappell, J. D., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A., Shapiro, N. I., Gibbs, K. W., Files, D. C., Hager, D. N., Shehu, A., Prekker, M. E., Erickson, H. L., … Self, W. H. (2022). Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: Prospective observational study. BMJ, 376, e069761. https://doi.org/10.1136/bmj-2021-069761

Jones, B., Wardman, L., & Tinkler, L. (2021, September 3). Coronavirus vaccine hesitancy in younger adults—Office for National Statistics. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/articles/coronavirusvaccinehesitancyinyoungeradults/june2021

Sanderson, K. (2021). COVID vaccines protect against Delta, but their effectiveness wanes. Nature. https://doi.org/10.1038/d41586-021-02261-8

Pan-Hammarström lab. (2022, January 7). Our new study: Heterogeneous vaccination strategy with inactivated vaccine + mRNA booster elicits strong B and T cell response against the WT and VOC including Omicron @VirusesImmunity https://t.co/aBiN9anMBL [Tweet]. @panhammarstrom. https://twitter.com/panhammarstrom/status/1479449892410044419

(1) ReconfigBehSci on Twitter: ‘RT @ahandvanish: New paper on 10,024 breakthrough infections shows that vaccination does not prevent #LongCovid. Https://t.co/8WurrqXRwy…’ / Twitter. (n.d.). Retrieved 29 October 2021, from https://twitter.com/SciBeh/status/1453638123624226822

ReconfigBehSci on Twitter: ‘@alexdefig are you really going to claim that responses to the introduction of passports on uptake across 4 other countries are evidentially entirely irrelevant to whether or not passports are justified or not?’ / Twitter. (n.d.). Retrieved 31 March 2022, from https://twitter.com/SciBeh/status/1444358068280565764

ReconfigBehSci. (2022, January 6). RT @GidMK: Perhaps unsurprisingly, this is an absolutely awful study filled with issues and numeric mistakes https://t.co/hvEv5gMMn2 [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1478987492552589314

University, G. W. (n.d.). Facebook’s vaccine misinformation policy reduces anti-vax information. Retrieved March 7, 2022, from https://medicalxpress.com/news/2022-03-facebook-vaccine-misinformation-policy-anti-vax.html

News ·, A. M. · C. (2022, January 15). Canadian COVID-19 vaccine study seized on by anti-vaxxers—Highlighting dangers of early research in pandemic | CBC News. CBC. https://www.cbc.ca/news/health/covid-19-vaccine-study-omicron-anti-vaxxers-1.6315890

APPG on Coronavirus. (2022, January 18). 🗣Dr.Claire Steves continued: “Looking in the national core studies, from cohort studies across the UK we’ve looked at 10 different longitudinal studies. Our best estimates are that about 5% of middle aged people are experiencing long term.. 27/ #APPGCoronavirus #LongCovid [Tweet]. @AppgCoronavirus. https://twitter.com/AppgCoronavirus/status/1483453895061999618

Mahase, E. (2021). Covid-19: Just a third of blood cancer patients had antibodies against delta variant after two vaccine doses, study finds. BMJ, 375, n2623. https://doi.org/10.1136/bmj.n2623

Prasad, V. (2021, September 30). Why Are Highly Vaxxed Colleges Implementing Strict COVID Policies? https://www.medpagetoday.com/opinion/vinay-prasad/94785

Tartof, S. Y., Slezak, J. M., Fischer, H., Hong, V., Ackerson, B. K., Ranasinghe, O. N., Frankland, T. B., Ogun, O. A., Zamparo, J. M., Gray, S., Valluri, S. R., Pan, K., Angulo, F. J., Jodar, L., & McLaughlin, J. M. (2021). Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. The Lancet, 398(10309), 1407–1416. https://doi.org/10.1016/S0140-6736(21)02183-8

For Teens with Obesity, COVID Vaccines Save Lives. (2021, October 21). ConscienHealth. https://conscienhealth.org/2021/10/for-teens-with-obesity-covid-vaccines-save-lives/

Mahase, E. (2021). Covid-19: Booster dose reduces infections and severe illness in over 60s, Israeli study reports. BMJ, 374, n2297. https://doi.org/10.1136/bmj.n2297

Hippisley-Cox, J., Coupland, C. A., Mehta, N., Keogh, R. H., Diaz-Ordaz, K., Khunti, K., Lyons, R. A., Kee, F., Sheikh, A., Rahman, S., Valabhji, J., Harrison, E. M., Sellen, P., Haq, N., Semple, M. G., Johnson, P. W. M., Hayward, A., & Nguyen-Van-Tam, J. S. (2021). Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: National prospective cohort study. BMJ, 374, n2244. https://doi.org/10.1136/bmj.n2244

Full Fact on Twitter. (n.d.). Twitter. Retrieved 20 September 2021, from https://twitter.com/FullFact/status/1439197512741658627

Kozlov, Max. ‘COVID-Vaccine Booster Shot Shows Promise in Israeli Study’. Nature, 16 September 2021. https://doi.org/10.1038/d41586-021-02516-4.

de Figueiredo, A., & Larson, H. J. (2021). Exploratory study of the global intent to accept COVID-19 vaccinations. Communications Medicine, 1(1), 1–10. https://doi.org/10.1038/s43856-021-00027-x

ElizabethB 🏡 on Twitter. (n.d.). Twitter. Retrieved 13 September 2021, from https://twitter.com/laughinggull6/status/1436329945773531137

Unvaccinated people were 11 times more likely to die of covid-19, CDC report finds. (n.d.). Washington Post. Retrieved 13 September 2021, from https://www.washingtonpost.com/health/2021/09/10/moderna-most-effective-covid-vaccine-studies/

Leif Erik Sander. “1/6 Our Study Comparing Reactogenicity & Immunogenicity of Homologous (2xBNT/Pfizer) vs Heterologous (AZ/ChAdOx +BNT) Vaccination Is Available Https://Medrxiv.Org/Content/10.1101/2021.05.19.21257334v2 Great Team Effort @vmcorman #FlorianKurth #DavidHillus #TatjanaSchwarz #PinkusToberLau et al. @ChariteBerlin 🧵 Https://T.Co/4zXfY4rV9c.” Tweet. @Sander_Lab (blog), June 2, 2021. https://twitter.com/Sander_Lab/status/1400178343123853321.

Mandavilli, A. (2021, August 6). New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot. The New York Times. https://www.nytimes.com/2021/08/06/science/johnson-delta-vaccine-booster.html

Dagan, Noa, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A. Katz, Miguel A. Hernán, Marc Lipsitch, Ben Reis, and Ran D. Balicer. ‘BNT162b2 MRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting’. New England Journal of Medicine 384, no. 15 (15 April 2021): 1412–23. https://doi.org/10.1056/NEJMoa2101765.

Iacobucci, Gareth. ‘Covid:19: Ethnic Minority Health Staff Are Less Likely to Take up Vaccine, Early Data Show’. BMJ 372 (16 February 2021): n460. https://doi.org/10.1136/bmj.n460.

Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P. R., Duarte-Salles, T., Suchard, M. A., Ryan, P. B., Hripcsak, G., & Prieto-Alhambra, D. (2021). Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: Multinational network cohort study. BMJ, 373, n1435. https://doi.org/10.1136/bmj.n1435

COVID-19 Breakthrough Case Investigations and Reporting | CDC. (2021, May 28). https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html

In-Depth: Delaying the second COVID-19 vaccine dose has benefits and drawbacks. (2021, May 20). KGTV. https://www.10news.com/news/in-depth/in-depth-delaying-the-second-covid-19-vaccine-dose-has-benefits-and-drawbacks

Eric Topol. (2021, May 1). Downgrading the concern on B.1.617, the poorly named ‘double mutant’—98% effectiveness of mRNA vaccine in an Israeli outbreak @CT_Bergstrom https://t.co/tGbuwPUmAL —Lab studies: Minimal immune evasion, expected full protection from vaccine @GuptaR_lab https://t.co/AIp24G0ROK https://t.co/AK20UWlDBD [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1388539223230140422

Vijayasingham, L., Bischof, E., & Wolfe, J. (2021). Sex-disaggregated data in COVID-19 vaccine trials. The Lancet, 397(10278), 966–967. https://doi.org/10.1016/S0140-6736(21)00384-6

Abdelhafiz, Ahmed Samir, Samar Abd ElHafeez, Mohammad Adnan Khalil, Manal Shahrouri, Bandar Alosaim, Raneem O. Salem, Mohamed Alorabi, Fatma Abdelgawad, and Mamoun Ahram. ‘Factors Influencing Participation in COVID-19 Clinical Trials: A Multi-National Study’. Frontiers in Medicine 8 (2021). https://doi.org/10.3389/fmed.2021.608959.

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study | Moderna, Inc. (n.d.). Retrieved 1 December 2020, from https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy/

Crotty, S. (2020, May 14). "Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multiple ways, including coronavirus vaccines. @ljiresearch cell.com/cell/fulltext/..." Twitter. https://twitter.com/profshanecrotty/status/1261052353773363200

Bertin, P., Nera, K., & Delouvée, S. (2020). Conspiracy beliefs, chloroquine, and the rejection of vaccination: A conceptual replication-extension in the COVID-19 pandemic context [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/rz78k

Adams, E. R., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E., Bell, J., Berry, T., Bibi, S., Carroll, M., Chinnakannan, S., Clutterbuck, E., Cornall, R. J., Crook, D. W., Silva, T. D., Dejnirattisai, W., Dingle, K. E., Dold, C., Eyre, D. W., … Sanchez, V. (2020). Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays. MedRxiv, 2020.04.15.20066407. https://doi.org/10.1101/2020.04.15.20066407

Callaway, E. (2020). Should scientists infect healthy people with the coronavirus to test vaccines? Nature, 580(7801), 17–17. https://doi.org/10.1038/d41586-020-00927-3

Credibull score = 5.58 / 10

To provide feedback on the score fill in the form available here

What is Credibull? getcredibull.com

Credibull score = 1.73 / 10

To provide feedback on the score fill in the form available here

What is Credibull? getcredibull.com